Logo image of GSUN

GOLDEN SUN HEALTH TECHNOLOGY (GSUN) Stock Fundamental Analysis

USA - NASDAQ:GSUN - KYG4013A1159 - Common Stock

2.98 USD
-0.06 (-1.97%)
Last: 9/19/2025, 8:14:23 PM
3.16 USD
+0.18 (+6.04%)
After Hours: 9/19/2025, 8:14:23 PM
Fundamental Rating

1

GSUN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 75 industry peers in the Diversified Consumer Services industry. GSUN may be in some trouble as it scores bad on both profitability and health. GSUN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GSUN had negative earnings in the past year.
In the past year GSUN has reported a negative cash flow from operations.
In multiple years GSUN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: GSUN reported negative operating cash flow in multiple years.
GSUN Yearly Net Income VS EBIT VS OCF VS FCFGSUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

GSUN has a Return On Assets of -50.01%. This is amonst the worse of the industry: GSUN underperforms 81.33% of its industry peers.
GSUN has a Return On Equity of -1180.68%. This is amonst the worse of the industry: GSUN underperforms 82.67% of its industry peers.
Industry RankSector Rank
ROA -50.01%
ROE -1180.68%
ROIC N/A
ROA(3y)-20.23%
ROA(5y)-6.12%
ROE(3y)-223.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSUN Yearly ROA, ROE, ROICGSUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

GSUN has a worse Gross Margin (11.08%) than 86.67% of its industry peers.
In the last couple of years the Gross Margin of GSUN has declined.
The Profit Margin and Operating Margin are not available for GSUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.54%
GM growth 5Y-15.35%
GSUN Yearly Profit, Operating, Gross MarginsGSUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

GSUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GSUN has been reduced compared to 1 year ago.
The number of shares outstanding for GSUN has been reduced compared to 5 years ago.
GSUN has a worse debt/assets ratio than last year.
GSUN Yearly Shares OutstandingGSUN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
GSUN Yearly Total Debt VS Total AssetsGSUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -0.68, we must say that GSUN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.68, GSUN is not doing good in the industry: 68.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 3.74 is on the high side and indicates that GSUN has dependencies on debt financing.
GSUN has a worse Debt to Equity ratio (3.74) than 76.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.74
Debt/FCF N/A
Altman-Z -0.68
ROIC/WACCN/A
WACC7.47%
GSUN Yearly LT Debt VS Equity VS FCFGSUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

GSUN has a Current Ratio of 0.71. This is a bad value and indicates that GSUN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.71, GSUN is doing worse than 70.67% of the companies in the same industry.
GSUN has a Quick Ratio of 0.71. This is a bad value and indicates that GSUN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.69, GSUN is doing worse than 69.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.69
GSUN Yearly Current Assets VS Current LiabilitesGSUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

GSUN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.26%, which is quite impressive.
The Revenue has grown by 65.03% in the past year. This is a very strong growth!
GSUN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.70% yearly.
EPS 1Y (TTM)39.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175%
Revenue 1Y (TTM)65.03%
Revenue growth 3Y-12.23%
Revenue growth 5Y-7.7%
Sales Q2Q%1072.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSUN Yearly Revenue VS EstimatesGSUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GSUN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSUN Price Earnings VS Forward Price EarningsGSUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSUN Per share dataGSUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GSUN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GOLDEN SUN HEALTH TECHNOLOGY

NASDAQ:GSUN (9/19/2025, 8:14:23 PM)

After market: 3.16 +0.18 (+6.04%)

2.98

-0.06 (-1.97%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)N/A N/A
Earnings (Next)02-02 2026-02-02
Inst Owners0.26%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap6.41M
AnalystsN/A
Price TargetN/A
Short Float %0.79%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 6.41
P/tB 6.41
EV/EBITDA N/A
EPS(TTM)-4.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.06
FCFYN/A
OCF(TTM)-5.01
OCFYN/A
SpS12.43
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.01%
ROE -1180.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.08%
FCFM N/A
ROA(3y)-20.23%
ROA(5y)-6.12%
ROE(3y)-223.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.54%
GM growth 5Y-15.35%
F-Score2
Asset Turnover1.57
Health
Industry RankSector Rank
Debt/Equity 3.74
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.98%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.69
Altman-Z -0.68
F-Score2
WACC7.47%
ROIC/WACCN/A
Cap/Depr(3y)97.54%
Cap/Depr(5y)146.09%
Cap/Sales(3y)2.32%
Cap/Sales(5y)2.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)65.03%
Revenue growth 3Y-12.23%
Revenue growth 5Y-7.7%
Sales Q2Q%1072.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y58.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.29%
OCF growth 3YN/A
OCF growth 5YN/A